Evolocumab ( AMG @ ) , a monoclonal antibody against proprotein convertase subtilisin/kexin type @ ( PCSK@ ) , significantly reduced low-density lipoprotein cholesterol ( LDL-C ) in phase @ studies of @ weeks ' duration .